Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 4:55 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 9,386 | $431.79 | $4,052,780.00 | (6%) 145.89K to 136.51K | |
| 21-Feb-24 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 7,019 | $420.58 | $2,952,050.00 | (5%) 152.91K to 145.89K | |
| 21-Feb-24 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 9,359 | $424.01 | $3,968,310.00 | (6%) 162.27K to 152.91K | |
| 13-Feb-24 5:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 8,255 | $422.74 | $3,489,720.00 | (5%) 170.53K to 162.27K | |
| 08-Feb-24 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 20,327 | -- | -- | 14% 150.2K to 170.53K | |
| 08-Feb-24 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 41,488 | -- | -- | 38% 108.71K to 150.2K | |
| 19-Dec-23 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Dec-23 | Option Exercise | 17,135 | $181.83 | $3,115,590.00 | 16% 108.71K to 125.85K | (7%) |
| 19-Dec-23 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Dec-23 | Planned Private Option Sale | 17,135 | $407.00 | $6,973,940.00 | (14%) 125.85K to 108.71K | |
| 15-Dec-23 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Dec-23 | Private Sale (Planned) | 5,098 | $397.00 | $2,023,910.00 | (4%) 113.81K to 108.71K | |
| 15-Nov-23 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Nov-23 | Private Sale (Planned) | 5,097 | $377.00 | $1,921,570.00 | (4%) 118.91K to 113.81K | |
| 18-Jul-23 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Jul-23 | Private Sale (Planned) | 7,828 | $355.00 | $2,778,940.00 | (6%) 126.73K to 118.91K | |
| 01-May-23 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Apr-23 | Private Sale (Planned) | 3,317 | $339.08 | $1,124,730.00 | (3%) 129.97K to 126.65K | |
| 28-Feb-23 4:53 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 9,386 | $289.12 | $2,713,680.00 | (7%) 139.35K to 129.97K | |
| 22-Feb-23 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 9,359 | $292.85 | $2,740,780.00 | (6%) 148.71K to 139.35K | |
| 14-Feb-23 4:58 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 5,990 | $298.26 | $1,786,580.00 | (4%) 154.7K to 148.71K | |
| 14-Feb-23 4:58 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 3,372 | $294.33 | $992,481.00 | (2%) 158.08K to 154.7K | |
| 03-Feb-23 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 68,478 | -- | -- | 76% 89.6K to 158.08K | |
| 27-Jan-23 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Jan-23 | Private Sale (Planned) | 10,000 | $315.05 | $3,150,500.00 | (10%) 99.6K to 89.6K | |
| 10-Nov-22 5:30 PM View: | Ginkgo Bioworks Holdings, I... (DNA) | 30-Sep-22 | Option Exercise | 9,818 | -- | -- | 14% 70.92K to 80.74K | |
| 17-Aug-22 5:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Aug-22 | Private Sale (Planned) | 11,689 | $305.06 | $3,565,850.00 | (11%) 111.29K to 99.6K | |
| 28-Jun-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Jun-22 | Private Sale (Planned) | 11,689 | $291.30 | $3,405,010.00 | (10%) 122.84K to 111.15K | |
| 13-Jun-22 9:12 PM View: | Ginkgo Bioworks Holdings, I... (DNA) | 10-Jun-22 | Grant | 70,921 | -- | -- | 100% 0 to 70.92K | |
| 28-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 7,246 | $227.86 | $1,651,070.00 | (6%) 130.09K to 122.84K | |
| 22-Feb-22 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 8,584 | $232.51 | $1,995,870.00 | (6%) 138.67K to 130.09K | |
| 14-Feb-22 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 3,031 | $237.74 | $720,590.00 | (2%) 141.7K to 138.67K | |
| 03-Feb-22 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 67,949 | -- | -- | 92% 73.75K to 141.7K | |
| 23-Aug-21 8:30 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Aug-21 | Purchase | 10,000 | $195.65 | $1,956,490.00 | 16% 63.75K to 73.75K | |
| 26-Feb-21 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 2,898 | $217.57 | $630,518.00 | (4%) 66.54K to 63.64K | |
| 19-Feb-21 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-21 | Payment of Exercise | 2,080 | $211.75 | $440,440.00 | (3%) 68.62K to 66.54K | |
| 12-Feb-21 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 2,962 | $214.16 | $634,342.00 | (4%) 71.58K to 68.62K | |
| 05-Feb-21 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 44,935 | -- | -- | 169% 26.65K to 71.58K | |
| 10-Aug-20 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Aug-20 | Option Exercise | 2,073 | $179.68 | $372,482.00 | 8% 26.63K to 28.7K | (6%) |
| 10-Aug-20 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Aug-20 | Planned Private Option Sale | 2,073 | $271.20 | $562,205.00 | (7%) 28.7K to 26.63K | |
| 19-May-20 4:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-May-20 | Private Sale (Planned) | 99 | $284.17 | $28,132.50 | (< 1%) 26.73K to 26.63K | |
| 08-May-20 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Option Exercise | 2,074 | $179.67 | $372,638.00 | 8% 26.63K to 28.7K | (6%) |
| 08-May-20 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Planned Private Option Sale | 2,074 | $272.85 | $565,882.00 | (7%) 28.7K to 26.63K | |
| 26-Feb-20 4:32 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-20 | Sale (Planned) | 3,634 | $233.45 | $848,371.00 | (12%) 30.26K to 26.63K | |
| 26-Feb-20 4:32 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-20 | Payment of Exercise | 2,898 | $239.23 | $693,288.00 | (9%) 33.16K to 30.26K | |
| 19-Feb-20 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-20 | Sale (Planned) | 1,183 | $243.51 | $288,070.00 | (3%) 34.34K to 33.16K | |
| 19-Feb-20 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-20 | Payment of Exercise | 944 | $241.50 | $227,976.00 | (3%) 35.28K to 34.34K | |
| 07-Feb-20 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-20 | Option Exercise | 2,074 | $179.67 | $372,638.00 | (5%) 39.43K to 37.36K | |
| 07-Feb-20 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-20 | Sale (Planned) | 2,074 | $239.44 | $496,599.00 | (6%) 37.36K to 35.28K | |
| 07-Feb-20 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-20 | Grant | 22,187 | -- | -- | 169% 13.1K to 35.28K | |
| 26-Nov-19 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Nov-19 | Option Exercise | 4,692 | $187.53 | $879,891.00 | 36% 13.1K to 17.79K | (10%) |
| 26-Nov-19 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Nov-19 | Planned Private Option Sale | 4,692 | $219.37 | $1,029,280.00 | (26%) 17.79K to 13.1K | |
| 19-Nov-19 4:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-19 | Private Sale (Planned) | 61 | $205.95 | $12,563.00 | (< 1%) 13.16K to 13.1K | |
| 13-Nov-19 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Nov-19 | Option Exercise | 509 | $155.57 | $79,185.10 | 4% 13.1K to 13.61K | |
| 13-Nov-19 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Nov-19 | Planned Option Sale | 509 | $199.00 | $101,291.00 | (4%) 13.61K to 13.1K | |
| 31-Oct-19 4:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Oct-19 | Option Exercise | 3,057 | $155.57 | $475,578.00 | 23% 13.1K to 16.16K | |
| 31-Oct-19 4:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Oct-19 | Planned Option Sale | 3,057 | $199.00 | $608,343.00 | (19%) 16.16K to 13.1K |